why choose us

Clinical Trials Search

Showing 15,750 of 132,963 result(s)
Retrospective Observational Comparison Study Between Ustekinumab and Tofacitinib as Third Line Therapy in a Multicenter Cohort of Patients With Refractory Ulcerative Colitis.

Status: Completed

Condition: Ulcerative Colitis

Interventions: Drug: Ustekinumab
a human monoclonal antibody to interleukin IL 12/23 p40. It is indicated in the treatment of adult patients with moderately to

Date: 2023-01-30

Durability at 20 Years of Quadrangular Resection With Annular Plication for Mitral Regurgitation

Status: Completed

Condition: Mitral Valve Disease

Interventions: Procedure: Quadrangular resection and annular plication
Mitral regurgitation is treated removing the redundant tissue of the posterior leaflet, w

Date: 2023-01-30

Long-term Outcomes of Isolated Tricuspid Valve Surgery According to Preoperative Clinical and Functional Staging

Status: Completed

Condition: Tricuspid Regurgitation

Interventions: Procedure: Tricuspid valve surgery
Surgical treatment of tricuspid regurgitation, that may be performed by repair or replacement

Date: 2023-01-30

A GBT021601 ADME Microtracer Study in Healthy Volunteers

Status: Active, not recruiting

Condition: Sickle Cell Disease

Interventions: Interventional

Date: 2023-01-30

The Effect of Virtual Reality on Preoperative Anxiety Before Abdominal Surgery

Status: Active, not recruiting

Condition: Anxiety

Interventions: Interventional

Date: 2023-01-30

Quantitative Assessment of the Efficacy of Sweeps Laser Activation Systems

Status: Completed

Condition: Periapical Periodontitis
Polymerase Chain Reaction
Enterococcus Faecalis Infection

Interventions: Interventional

Date: 2023-01-30

Mini-dose Esketamine-dexmedetomidine Supplemented Analgesia and Long-term Outcomes

Status: Active, not recruiting

Condition: Scoliosis Correction
Postoperative Analgesia
Esketamine
Dexmedetomidine
Chronic

Interventions: Interventional

Date: 2023-01-30

AN OBSERVATIONAL STUDY ON CARDIOVASCULAR INVOLVEMENT IN COVID RECOVERED PATIENTS

Status: Completed

Condition: Gender Discrimination
Cardiac Event
Complication

Interventions: Behavioral: Difference in gender, response to disease, diagnostic test values
Gender difference: Prevalence of disease in male vs female Response

Date: 2023-01-30

Impact of Adalimumab Withdrawal or Continuation on Severity of COVID-19 and Risk of IMID Relapse

Status: Completed

Condition: Inflammatory Bowel Diseases
Rheumatic Disorder

Interventions: Drug: Adalimumab
Adalimumab is a fully human, high-affinity, recombinant anti-tumor necrosis factor (TNF) alpha monoclonal antibody used to treat

Date: 2023-01-30